Cladribine is a safe and effective treatment for highly active relapsing-remitting multiple sclerosis

被引：0
作者：
Suslak, T. [1 ]
Macdougall, N. [2 ]
Murray, L. [1 ]
机构：
[1] NHSGGC, Glasgow, Lanark, Scotland
[2] NHSGGC, NHSL, Glasgow, Lanark, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0309
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [31] A BUDGET IMPACT ANALYSIS OF CLADRIBINE IN ENGLAND AND WALES FOR PATIENTS WITH HIGHLY ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS (HA-RRMS)
    Herbert, A.
    Ashton, L.
    Alexopoulos, S. T.
    VALUE IN HEALTH, 2023, 26 (12) : S119 - S119
  • [32] How does fingolimod (Gilenyal fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
    Fazekas, Franz
    Bajenaru, Ovidiu
    Berger, Thomas
    Fabjan, Tanja Hojs
    Ledinek, Alenka Horvat
    Jakab, Gabor
    Komoly, Samuel
    Kobys, Tetiana
    Kraus, Joerg
    Kurca, Egon
    Kyriakides, Theodoros
    Lisy, L'ubomir
    Milanov, Ivan
    Nehrych, Tetyana
    Moskovko, Sergii
    Panayiotou, Panayiotis
    Jazbec, Sasa Sega
    Sokolova, Larysa
    Talab, Radomir
    Traykov, Latchezar
    Turcani, Peter
    Vass, Karl
    Vella, Norbert
    Voloshyna, Nataliya
    Havrdova, Eva
    FRONTIERS IN NEUROLOGY, 2013, 4
  • [33] What is the effective dose of intravenous immunoglobulin for treatment of relapsing-remitting multiple sclerosis?
    Lewanska, M
    Siger-Zajdel, M
    Selmaj, K
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 243 - 255
  • [34] Oral simvastatin treatment in relapsing-remitting multiple sclerosis
    Vollmer, T
    Key, L
    Durkalski, V
    Tyor, W
    Corboy, J
    Markovic-Plese, S
    Preiningerova, J
    Rizzo, M
    Singh, L
    LANCET, 2004, 363 (9421) : 1607 - 1608
  • [35] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [36] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [37] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Vosiliou, S.
    DRUGS OF TODAY, 2010, 46 (05) : 315 - 325
  • [38] Longitudinally Extensive Transverse Myelitis in a Patient with Highly Active Relapsing-Remitting Multiple Sclerosis
    Ng, C. F.
    Kutty, S. Koya
    Zaidi, W. A. Wan
    Remli, R.
    Tan, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 483 - 484
  • [39] Natalizumab is effective in patients with active relapsing-remitting multiple sclerosis: a Middle Eastern experience
    Alroughani, R.
    Al Hashel, J.
    Ahmed, S.
    Thussu, A.
    JOURNAL OF NEUROLOGY, 2013, 260 : S66 - S66
  • [40] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
12345